Our review highlights strong evidence of a protective role of antihypertensive drugs, specifically ACE inhibitors and CCBs, in CHD, stroke, post-stroke functional outcomes, diabetes, and kidney function, which is supported by evidence from RCTs [55–62], as well as national and international guidelines [81–84]. The gene discussed is ACE; the disease is coronary artery disorder.